November 19, 2021 KCCure is offering a grant totaling $50,000 for a project focused on innovative scientific research in chromophobe renal cell carcinoma (RCC)....Read More
The FDA approval of adjuvant Keytruda is a significant advancement in the treatment of renal cell carcinoma. Immune based adjuvant therapy provides an exciting ...Read More
Forgot your password?
No account? Sign up
Please enter your username or email address. You will receive a link to create a new password via email.
Already have an account? Login instead